$GILD Recent Headlines Gilead says EU Committee to

New Post Public Reply Private Reply Replies (0) Message Board

Aug 2, 2014 at 10:35 AM

$GILD Recent Headlines

Gilead says EU Committee to recommend approval of leukemia drug 7:32 a.m. July 25, 2014 - Ciara Linnane
Gilead says EU Committee to recommend approval of leukemia drug 7:26 a.m. July 25, 2014 - Ciara Linnane
S&P 500 ekes out another record close: stock market live blog recap 4:03 p.m. July 24, 2014 - blogs.marketwatch.com
Facebook surges to record; SodaStream bubbles higher 1:23 p.m. July 24, 2014 - Tom Bemis
Biotechs beat estimates, but the Street wants more 11:44 a.m. July 24, 2014 - blogs.marketwatch.com
Gilead trounces earnings views, but shares don't feel the after-hours love 5:39 p.m. July 23, 2014 - blogs.marketwatch.com
Updates, advisories and surprises 5:31 p.m. July 23, 2014 - MarketWatch
Facebook rallies in after hours as results top outlook 4:58 p.m. July 23, 2014 - Sue Chang
Biogen results crush consensus 4:55 p.m. July 23, 2014 - The Trading Deck
Gilead trounces estimates on strong Sovaldi sales 4:19 p.m. July 23, 2014 - MarketWatch.com
Gilead trounces estimates for earnings, sales, Sovaldi 4:17 p.m. July 23, 2014 - Russ Britt
Gilead Sovaldi sales reach $3.48B, ahead of $2.87B view 4:10 p.m. July 23, 2014 - Russ Britt
Gilead's $6.53B in revs. beats $5.85B estimate 4:10 p.m. July 23, 2014 - Russ Britt
Gilead adj. earns are $2.36/share vs. view of $1.79 4:09 p.m. July 23, 2014 - Russ Britt
Gilead revs. $6.5 billion vs. year-ago $2.77 billion 4:08 p.m. July 23, 2014 - Russ Britt
Gilead Q2 net is $2.20 vs. year-ago 46 cents 4:07 p.m. July 23, 2014 - Russ Britt
4 ways Gilead’s earnings will impact every American 1:30 p.m. July 23, 2014 - Tim Mullaney
Gilead's moment of truth arrives: How does Sovaldi impact earnings? 1:18 p.m. July 23, 2014 - blogs.marketwatch.com
CVS officials say Sovaldi pricing in line with history, but unsustainable 3:36 p.m. July 20, 2014 - blogs.marketwatch.com
Nasdaq needs to turn up the volume 11:59 a.m. July 17, 2014 - The Trading Deck

A Quick Look At 2 Small-Cap Bio-Pharmaceutical Companies: Discovery Labs And Exelexis 9:22 p.m. Aug. 1, 2014 - Seeking Alpha
TAL Education, Team Health Join The IBD 50 Resistance 6:08 p.m. Aug. 1, 2014 - Investors Business Daily
Pharmacyclics Q2 Earnings Get Mixed Reception 11:35 a.m. Aug. 1, 2014 - Investors Business Daily
Micron: Maybe It Isn't Different This Time 1:30 p.m. July 31, 2014 - Seeking Alpha
Amgen Makes the Cut 12:25 p.m. July 31, 2014 - Barrons.com
A Tough Market For The 'Risk On' Investor 10:50 a.m. July 31, 2014 - Seeking Alpha
Stock Market News for July 31, 2014 - Market News 10:10 a.m. July 31, 2014 - Zacks.com
Biotech Earnings Put These ETFs in Focus - ETF News And Commentary 10:01 a.m. July 31, 2014 - Zacks.com
3 Biotech Catalyst Stocks To Own 9:04 a.m. July 31, 2014 - Seeking Alpha
Biotech Valuations Are Low Not Stretched. Here's Why. 8:35 a.m. July 31, 2014 - TheStreet.com
Cramer's Lightning Round - 6 Biotech Picks (7/30/14) 6:35 a.m. July 31, 2014 - Seeking Alpha
7 Stocks With High Sales Growth To Watch After Yesterday's GDP Data 6:06 a.m. July 31, 2014 - Seeking Alpha
Can the Earnings Rebound be Sustained? - Earnings Trends 3:34 a.m. July 31, 2014 - Zacks.com
Can the Earnings Rebound be Sustained? - Earnings Outlook 3:34 a.m. July 31, 2014 - Zacks.com
Jim Cramer's 'Mad Money' Recap: Thinking 5 Steps Ahead and Being Wrong 7:55 p.m. July 30, 2014 - TheStreet.com
Merck, J&J, Baxter Provide Healthy Dividend Stream 6:01 p.m. July 30, 2014 - Investors Business Daily
WellPoint Lifts View Despite Profit Drop 12:04 p.m. July 30, 2014 - The Wall Street Journal Interactive Edition
Biotech Stock Roundup: Gilead's Sovaldi & Biogen's Tecfidera Impressive Run Continues - Analyst Blog 12:04 p.m. July 30, 2014 - Zacks.com
Why Humana (HUM) Stock Is Declining Today 11:58 a.m. July 30, 2014 - TheStreet.com
Stock Market News for July 30, 2014 - Market News 10:10 a.m. July 30, 2014 - Zacks.com

Complete Response Letter from FDA, Positive Opinion on Drug, Technical Update, Financial Result Release, and Clinical Trial Results - Research Reports on AcelRx, Horizon, Gilead, AbbVie and Exelixis 9:20 a.m. July 31, 2014 - PR Newswire - PRF
Market Momentum on Biotech Stocks -- IsoRay, Neurocrine Biosciences, OPKO Health, Orexigen Therapeutics, and Gilead Sciences 8:40 a.m. July 31, 2014 - PR Newswire - PRF
Theraclone Announces Exclusive Agreement with Gilead Sciences for Broadly Neutralizing HIV Antibodies 8:00 a.m. July 30, 2014 - BusinessWire - BZX
European CHMP Adopts Positive Opinion for Gilead’s Zydelig® (idelalisib) for the Treatment of Chronic Lymphocytic Leukemia and Follicular Lymphoma 7:24 a.m. July 25, 2014 - BusinessWire - BZX
Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic 10:03 a.m. July 24, 2014 - ACCESSWIRE
The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF) 12:30 a.m. July 24, 2014 - PR Newswire - PRF
Gilead Announces New Agreement with Medicines Patent Pool for Access to Medicines in Developing World Countries 12:00 a.m. July 24, 2014 - BusinessWire - BZX
U.S. Food and Drug Administration Approves Gilead’s Zydelig® (idelalisib) for Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma 11:49 a.m. July 23, 2014 - BusinessWire - BZX
Gilead Sciences to Release Second Quarter 2014 Financial Results on Wednesday, July 23, 2014 5:00 p.m. July 16, 2014 - BusinessWire - BZX
Critical Alerts For SunEdison, Twitter, Gilead Sciences, Darden Restaurants, and Blackrock Released By InvestorsObserver 9:31 a.m. July 14, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
Dividends, Mergers, and Study Results - Analyst Notes on Pfizer, Gilead, Pacira, QLT and Agenus 6:30 a.m. July 1, 2014 - PR Newswire - PRF
AIDSVu Releases New Maps that Depict Impact of HIV in American Cities 9:50 a.m. June 27, 2014 - BusinessWire - BZX
Top White House AIDS Official Visits San Francisco Clinic on National HIV Testing Day 9:00 a.m. June 27, 2014 - PR Newswire - PRF
Gilead Submits New Drug Application to Japan’s Pharmaceutical and Medical Devices Agency for Sofosbuvir for Chronic Hepatitis C 3:01 a.m. June 27, 2014 - BusinessWire - BZX
Biotechnology Equities Technical Notes -- Research on StemCells, Gilead Sciences, Galena Biopharma, and Inovio Pharma 7:10 a.m. June 26, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the Wells Fargo Healthcare Conference on Tuesday, June 17 5:00 p.m. June 16, 2014 - BusinessWire - BZX
Gilead Announces Phase 3 Data Showing That the Fixed-Dose Combination of Ledipasvir/Sofosbuvir Achieved 100 Percent Sustained Virologic Response (SVR12) Among Patients with Chronic Hepatitis C in Japan 8:00 p.m. June 15, 2014 - BusinessWire - BZX
Anthera Pharmaceuticals Appoints Dr. Philip Sager to Board of Directors 3:30 p.m. June 13, 2014 - PR Newswire - PRF
Critical Alerts For Ralph Lauren, Rackspace Hosting, Gilead Sciences, Fortinet, and Express Scripts Technology Released By InvestorsObserver 9:31 a.m. June 13, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HK Boosts Oversight of Building Repairs Post-Blaze

Big Moves After a Tragic Fire Hong Kong's revamping its approach to building maintenance and oversight, clearly in reaction to the horrific Wang Fuk Court blaze last year. That fire didn't just leave scars; it blew open glaring gaps in the city's oversight of building repairs. The government's now jumping into action by launching a raft of measures aimed at preventing...

Race for Life Rescue Logs 200 Flights for Shelter Pets

Airborne Lifelines for Vulnerable Animals Ever picture an airplane filled with hope? Well, Race for Life Rescue isn't just carting metal through the sky; they're lifting spirits, one furry passenger at a time. Picture this: a nonprofit turning a clunky Beechcraft into a flying ark, whisking away 112 at-risk pets from Louisiana to fresh starts in the Northeast. And guess...

Fluence Energy Faces Class Action: Investors Beware

Storm Clouds Over Fluence Energy I'll tell you, I ain't surprised when companies face the music for dressing up their books. Fluence Energy, Inc. (NASDAQ: FLNC)—those wallopers are now caught in a legal maelstrom with a securities fraud class action lawsuit hanging over their heads. It's hard to feel sorry for 'em when the writing's on the wall. Allegations and...

XPeng Hits New Monthly Delivery Record in October

XPeng Smashes Delivery Records Yet Again Ah, the green light’s on for XPeng, and it's a bright one! This October, we learned that XPeng hit the throttle hard with a new record of 50,237 vehicles delivered. Now, that's a sizable rally—a 22% climb month-over-month and shooting 20% higher than last October. For a company like XPeng, which resembles a bulldog with its...

DKS Lawsuit Deadline: Investors Must Act by Nov 3, 2026

Clock's Ticking for DICK'S Investors If you've got money tied up in DICK'S Sporting Goods—bought between September 8, 2025, and August 24, 2026—listen up. There's a class action lawsuit aiming to recover some of what might've slipped through your fingers. Come November 3, 2026, the door slams shut on your chance to get involved. What's the Beef? Apparently, DICK'S had...

Bass Angler Matt Robertson Reels in Record $1.25M Prize

A New Era for Bass Fishing Payouts Who would have thought we'd see the day when bass fishing turned out to be as lucrative as a Wall Street handshake? But here we are, with Matt Robertson hauling in a whopping $1.25 million prize at World Bass Enterprises' first "The Champions" Tournament. We're not talking chump change here—this is the real deal in a sport often...

Naviu's AI Travel Guide: Revolutionizing Japan Tours

A New Era of Touring Japan: Meet Naviu Alright, travelers, strap in—Naviu is about to flip your trip to Japan upside down. Launching November 1st, 2026, this AI-powered augmented reality travel companion is trying to make exploring Japan easier than ever. Behind this innovative gem is TANGLE Inc., working with technology so cutting-edge, it's practically slicing through...

NABEP's Strategic Push: 41 Rigs to Bolster Output

On The Ground: NABEP's Expanding Venezuelan Presence Think of oil production as a high-stakes poker game where each drill and rig is a well-placed bet. North American Blue Energy Partners (NABEP) is going all in on Venezuela, boosting their rig fleet and pushing production capacity to new heights. Set your sights on November when NABEP's in-country fleet will hit 41 rigs...

Yangtze River Culture Festival Spotlights Integration, Tradition

A Celebration of Culture and Integration Here's an event that flips the script on the typical festival circuit: the 2026 Yangtze River Culture Festival. It's as much about heritage as it is about economics, dovetailing culture with tourism in a way that makes wallets a little fatter and souls a little richer. Kicking off in Yonglian Village, Zhangjiagang, this festival...

GAC Dominates with 8 Awards in Cutting-Edge Tech

GAC's Moment in the Spotlight Wow, did ya hear about GAC grabbing eight shiny awards at the China-SAE Science and Technology gig? That ain't small potatoes, especially when you're bagging four first prizes. These fellas in Suzhou on October 28 sure showed they're not just playing in the sandbox but are ready to build the darn thing. There's power, and then there's GAC's...